Search results
Horizon (HZNP) Marketed Drugs Aid Growth, Stiff Rivalry a Woe
Zacks via Yahoo Finance· 2 years agoHorizon's (HZNP) portfolio of marketed drugs, including Tepezza and Krystexxa, aid growth. The...
Horizon's (HZNP) Daxdilimab Fails to Meet Goal in Lupus Study
Zacks via Yahoo Finance· 9 months agoHorizon Therapeutics plc HZNP announced the failure of the phase II study evaluating daxdilimab for...
Horizon Therapeutics (NASDAQ:HZNP) delivers shareholders massive 48% CAGR over 5 years, surging 3.2%...
Simply Wall St. via Yahoo Finance· 2 years agoIt hasn't been the best quarter for Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)...
Horizon (HZNP) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
Zacks via Yahoo Finance· 2 years agoHorizon's (HZNP) earnings and revenues lag estimates in the second quarter of 2022. The company...
Horizon's (HZNP) Q3 Earnings & Revenues Surpass Estimates
Zacks via Yahoo Finance· 1 year agoHorizon Therapeutics plc HZNP reported third-quarter 2022 adjusted earnings of $1.25 per share,...
FTC May Reportedly Block Amgen's (AMGN) $28B Horizon Buyout
Zacks via Yahoo Finance· 12 months agoShares of Horizon Therapeutics HZNP were down 15% in after-market trading on May 15 after multiple...
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoNovo Nordisk A/S NVO is scheduled to release its second-quarter 2022 results on Aug 4. The company’s...
FTC Challenges Amgen's (AMGN) $28B Acquisition of Horizon
Zacks via Yahoo Finance· 12 months agoPer the FTC, Amgen's (AMGN) acquisition of Horizon (HZNP) would entrench the monopoly positions for...